Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study was to evaluate the efficacy, safety and tolerability of intravenous
infusion of serelaxin, when added to standard therapy, in acute heart failure (AHF) patients.